Watch our capabilities presentation to learn how our integrated CDMO solutions accelerate immune cell therapy development from early-phase to commercial readiness.
Research Triangle Park, NC — Kincell Bio, a leading contract development and manufacturing organization (CDMO) in cell therapy, today announced the promotion of three accomplished executives...
This webinar explores how integrated PD/AD expertise can deliver robust, regulatory-ready assays and accelerates cell therapy development.
Scientific breakthroughs are outpacing the systems needed to deliver them, including reimbursement models, manufacturing infrastructure, and traditional biotech business frameworks.
Scientific breakthroughs are outpacing the systems needed to deliver them, including reimbursement models, manufacturing infrastructure, and traditional biotech business frameworks.
Research Triangle Park, NC — Kincell Bio, a leading contract development and manufacturing organization (CDMO) in cell therapy, today announced the promotion of three accomplished executives...
Read MoreMark R. Bamforth OBE Transitions to Executive Chair of the Board, Strengthening Strategic Leadership at Kincell Bio Research Triangle Park, NC — Kincell Bio, a leading...
Read MoreAs allogeneic cell therapies advance toward commercialization, manufacturers must adopt automation and flexible facility designs to improve scalability, consistency, and cost efficiency.
This webinar explores how integrated PD/AD expertise can deliver robust, regulatory-ready assays and accelerates cell therapy development.
For cell therapy developers, early-phase speed without a clear CMC roadmap is extremely risky; however, overengineering early-phase work is too slow and costly. The programs...
Read Now
1622 NW 55th Place
Gainesville, FL 32653
20 TW Alexander Dr, Suite 130
RTP, NC 27713
